NomosLogic

Media Coverage

NomosLogic in the Press

Coverage, publications, and media mentions from leading industry outlets.

Mark8Access

Mark8Access-NomosLogic Launches Molecular Medicine Infrastructure

NomosLogic has introduced a new molecular medicine infrastructure designed for consumer genomics, integrating multi-omic data with deterministic disease modeling. The platform aims to enhance precision health insights by combining genomics, proteomics, and other biological datasets into a unified system. This advancement is positioned to improve early disease prediction, personalized treatment strategies, and scalable health analytics for both individuals and healthcare providers.

April 15, 2026Read Article

ADVFN

ADVFN - NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

The platform is protected by a broad patent portfolio spanning nomenclature resolution, deterministic clinical logic architecture, multi-omic fusion, evolutionary simulation, and state-faithful systems visualization. NomosLogic is currently in active clinical validation and partnership discussions across consumer genomics, payer, and pharmaceutical markets.

April 14, 2026Read Article

Caledonian Record

Caledonian Record - NomosLogic Clinical Genomics Infrastructure

NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease susceptibility, and systems-level health modeling.

April 14, 2026Read Article

Rutland Herald

Rutland Herald - NomosLogic

NomosLogic is building infrastructure for molecular medicine. The company's platform integrates deterministic genomic interpretation, multi-omic fusion, distributed disease modeling, patient-facing insight generation, and governance-grade auditability into a unified infrastructure layer for health systems, consumer genomics platforms, payers, and biopharma.

April 13, 2026Read Article

Times Argus

Times Argus - NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

Consumer genomics platforms, health systems, health plans, and biopharma organizations already sit on enormous genomic and clinical data assets. What is missing is the infrastructure layer that makes those assets clinically usable.

April 13, 2026Read Article

Joplin Globe

Joplin Globe - Genomics has never really had an interpretation problem at the level of data availability. It has had an infrastructure problem.

“Genomics has never really had an interpretation problem at the level of data availability. It has had an infrastructure problem. The data already exists. What has been missing is the molecular medicine layer that can deterministically turn that data into medication guidance, disease architecture, and health intelligence that people can actually use.”

April 13, 2026Read Article

Bakersfield.com

Bakersfield.com - NomosLogic operates as an infrastructure layer for molecular medicine rather than a point product

NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease susceptibility, and systems-level health modeling.

April 13, 2026Read Article

GenomeWeb

GenomeWeb - NomosLogic Dendrite Lite, Clinical Standalone

NomosLogic has launched Dendrite Lite, a genomic health platform for consumers that provides pharmacogenomic findings to individuals with DNA data, and Clinical Standalone engine for health systems and clinical partners. According to the Utah-based company, the platforms provide "deterministic output" – findings that are reproducible, auditable, and traceable to evidence – along with clinical-grade evidence. Its Dendrite Lite consumer platform, which costs $99, $149, or $249 depending on the tier selected, accepts DNA files from 23andMe, AncestryDNA, and MyHeritage and generates a report in about 2 minutes.

April 13, 2026Read Article

BussinessWire

BusinessWire - NomosLogic launched molecular medicine infrastructure for deterministic genomic interpretation, multi-omic fusion, and disease modeling.

The data already exists. What has been missing is the molecular medicine layer that deterministically turns data into medication guidance and usable health intelligence.

April 13, 2026Read Article

Morningstar

Morningstar Press Release - NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

NomosLogic is building infrastructure for molecular medicine. The company's platform integrates deterministic genomic interpretation, multi-omic fusion, distributed disease modeling, patient-facing insight generation, and governance-grade auditability into a unified infrastructure layer for health systems, consumer genomics platforms, payers, and biopharma.

April 13, 2026Read Article

Yahoo Finance

Yahoo Finance - NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

Consumer genomics platforms, health systems, health plans, and biopharma organizations already sit on enormous genomic and clinical data assets. What is missing is the infrastructure layer that makes those assets clinically usable.

April 13, 2026Read Article

AP Press

AP Press - NomosLogic Introduces Molecular Medicine Infrastructure for Consumer Genomics, Multi-Omic Fusion, and Deterministic Disease Modeling

“Genomics has never really had an interpretation problem at the level of data availability. It has had an infrastructure problem. The data already exists. What has been missing is the molecular medicine layer that can deterministically turn that data into medication guidance, disease architecture, and health intelligence that people can actually use.”

April 13, 2026Read Article